These data points suggest that GLP-1 receptor activation itself, rather than any semaglutide-specific property, may be responsible for the allodynia risk
Crowley is a member of Lambda Kappa Sigma, United Food and Commercial Workers, the California Pharmacists Association, Los Angeles County Federation of Labor, and Phi Lambda Sigma
Lower Risk of Hypoglycemia: Compared to some other diabetes medications, semaglutide carries a reduced risk of causing hypoglycemia, ensuring safer blood sugar management
Nosebleeds arent usually an indication of a more serious health concern
After people eat, GLP-1 is released from the intestines
For a broader understanding of the GLP-1 medication class, the relationship explained in our guide on whether GLP-1 is the same as Ozempic clarifies how different medications in this category share fundamental timing principles while differing in their specific pharmacokinetic profiles